Literature DB >> 11924826

Candida: a causative agent of an emerging infection.

M A Ghannoum1.   

Abstract

Incidences of infections due to Candida have increased over the last 15-20 y. This increase in the incidence and the high associated mortality rate despite therapy has focused the attention on this disease and prompted investigators to undertake research aimed at understanding the pathogenesis of this disease as well as methods to treat it. This paper discusses recent developments in the Candida field and the impact they have on patient management.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11924826     DOI: 10.1046/j.0022-202x.2001.00047.x

Source DB:  PubMed          Journal:  J Investig Dermatol Symp Proc        ISSN: 1087-0024


  5 in total

1.  Use of quantitative real-time PCR to study the kinetics of extracellular DNA released from Candida albicans, with implications for diagnosis of invasive Candidiasis.

Authors:  Miki Kasai; Andrea Francesconi; Ruta Petraitiene; Vidmantas Petraitis; Amy M Kelaher; Hee-Sup Kim; Joseph Meletiadis; Tin Sein; John Bacher; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

Review 2.  Combination treatment of invasive fungal infections.

Authors:  Pranab K Mukherjee; Daniel J Sheehan; Christopher A Hitchcock; Mahmoud A Ghannoum
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Effects of antifungal agents in sap activity of Candida albicans isolates.

Authors:  Carolina Rodrigues Costa; Rosália Santos Amorim Jesuíno; Janine de Aquino Lemos; Orionalda de Fátima Lisboa Fernandes; Lúcia Kioko Hasimoto e Souza; Xisto Sena Passos; Maria do Rosário Rodrigues Silva
Journal:  Mycopathologia       Date:  2009-08-15       Impact factor: 2.574

4.  7-hydroxycalamenene Effects on Secreted Aspartic Proteases Activity and Biofilm Formation of Candida spp.

Authors:  Mariana M B Azevedo; Catia A Almeida; Francisco C M Chaves; Igor A Rodrigues; Humberto R Bizzo; Celuta S Alviano; Daniela S Alviano
Journal:  Pharmacogn Mag       Date:  2016 Jan-Mar       Impact factor: 1.085

5.  Susceptibility testing of Candida albicans isolated from oropharyngeal mucosa of HIV(+) patients to fluconazole, amphotericin B and Caspofungin. killing kinetics of caspofungin and amphotericin B against fluconazole resistant and susceptible isolates.

Authors:  Janine de Aquino Lemos; Carolina Rodrigues Costa; Crystiane Rodrigues de Araújo; Lúcia Kioko Hasimoto E Souza; Maria do Rosário Rodrigues Silva
Journal:  Braz J Microbiol       Date:  2009-03-01       Impact factor: 2.476

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.